Turing Pharmaceuticals is in the
spotlight this week in the US after
it raised the price of toxoplasmosis
drug Daraprim from US$13.50 to a
whopping $750 per tablet.
The revelations - and political
pressure from Presidential aspirants
around drug pricing - drove the
value of biotech stocks down.
Turing ceo Martin Shkreli said the
company would lower the price to
be more affordable, but said the
US$55 million cost of acquiring the
drug justified part of the increase.The above article was sent to subscribers in Pharmacy Daily's issue from 24 Sep 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Sep 15
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.